2001 (11) TMI 141 - AT - Central Excise

Summary

The Appellate Tribunal CEGAT, New Delhi upheld the decision allowing Modvat credit on various items used as capital goods in the manufacturing process of Bulk Drugs Intermediates. The appeal by the Revenue was dismissed as the items were found to meet the criteria under Rule 57Q. The respondents did not appear for the hearing, but their cross objections were also dismissed.